已收盤 02-06 16:00:00 美东时间
-0.160
-7.14%
Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent yearsSAN DIEGO,
02-06 20:10
Cibus shares are trading lower after the company announced a proposed public of...
01-29 05:52
Cibus, Inc. (Nasdaq: CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A
01-29 05:24
Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the CaribbeanExpected to build on success under the existing
01-05 20:15
Cibus和Interoc签署非约束性意向书,计划从2027年开始在厄瓜多尔和哥伦比亚推广抗除草剂水稻性状,之后扩展到秘鲁、中美洲及加勒比地区。合作旨在通过抗除草剂技术帮助拉美种植者提高产量,解决杂草问题。
01-05 12:00
Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growersThe agreed
2025-12-11 20:10
Cibus shares are trading lower after the company reported worse-than-expected Q...
2025-11-14 05:17
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
Cibus, Inc. announced the election of Craig Wichner to its Board of Directors and Strategy Committee. Wichner, a leader in farmland investment and sustainable agriculture, brings expertise in financial strategy and industry insight. His experience in regenerative farming and agricultural innovation aligns with Cibus' goal to drive sustainable crop development. Wichner’s加入 bolstering Cibus’ position in the agricultural market and aiding in creatin...
2025-11-11 12:00
Cibus, Inc. will release its third quarter 2025 financial results on November 13, 2025, followed by a conference call and audio webcast at 4:30 p.m. ET. Participants can join via +1-800-274-8461 (U.S.) or +1-203-518-9814 (International) using the conference ID "CIBUS" or 24287. A replay will be available until November 27, 2025, and an audio webcast with slides will be accessible on investor.cibus.com. Cibus, a leader in gene-edited traits for cr...
2025-10-30 20:05